Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease

Journal of Medicinal Chemistry

Volumn 39, Issue 13, 1996, Pages 2472-2481

  Mazumder, Abhijit ^a   Wang, Shaomeng ^a   Neamati, Nouri ^a   Nicklaus, Marc ^a   Sunder, Sanjay ^a   Chen, Julie ^a   Milne, George W A ^a   Rice, William G ^b   Burke Jr , Terrence R ^a   Pommier, Yves ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYCOUMARIN; ANTIVIRUS AGENT; DNA TOPOISOMERASE; INTEGRASE; NSC 117027; NSC 158393; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS ENZYME;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; FELINE IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; MOLECULAR MODEL; NONHUMAN; RETROVIRUS; SIMIAN IMMUNODEFICIENCY VIRUS;

4-HYDROXYCOUMARINS; ANTIVIRAL AGENTS; BASE SEQUENCE; BINDING SITES; DNA NUCLEOTIDYLTRANSFERASES; DNA TOPOISOMERASES, TYPE I; DNA, VIRAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME INHIBITORS; HIV PROTEASE INHIBITORS; HIV-1; INTEGRASES; MODELS, CHEMICAL; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; NAPHTHOQUINONES; POLYDEOXYRIBONUCLEOTIDES; QUINONES; STRUCTURE-ACTIVITY RELATIONSHIP; ULTRAVIOLET RAYS;

EID: 15844424316     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm960074e     Document Type: Article

References (29)

1. De Clercq, E. Toward improved anti-HIV chemotherapy: therapeutic strategies for intervention with HIV infections. J. Med. Chem. 1995, 38, 2491-2517.
2. Mazumder, A.; Gazit, A.; Levitzki, A.; Nicklaus, M.; Yung, J.; Kohlhagen, G.; Pommier, Y. Effects of Tyrphostins, Protein Kinase Inhibitors, on Human Immunodeficiency Virus Type 1 Integrase. Biochemistry 1995, 34, 15111-15122.
3. LaFemina, R. L.; Graham, P. L.; LeGrow, K.; Hastings, J. C.; Wolfe, A.; Young, S. D.; Emini, E. A.; Hazuda, D. J. Inhibition of human immunodeficiency virus integrase by bis-catechols. Antimicrob. Agents Chemother. 1995, 39, 320-324.
4. Carteau, S.; Mouscadet, J. F.; Goulaouic, H.; Subra, F.; Auclair, C. Inhibitory effect of the polyanionic drug suramin on the in vitro HIV DNA integration reaction. Arch. Biochem. Biophys. 1993, 305, 606-610.
5. Mazumder, A.; Cooney, D.; Agbaria, R.; Gupta, M.; Pommier, Y. Inhibition of human immunodeficiency virus type 1 integrase by 3′-azido-3′-deoxythymidylate Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 5771-5775.
6. Cushman, M.; Golebiewski, W. M.; Pommier, Y.; Mazumder, A.; Reymen, D.; De Clerq, E.; Graham, L.; Rice, W. G. Cosalane analogues with enhanced potencies as inhibitors of HIV-1 protease and integrase. J. Med. Chem. 1995, 38, 443-452.
7. Wiskerchen, M. A.; Muesing, M. A. Human immunodeficiency virus type 1 integrase: effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells. J. Virol. 1995, 69, 376-386.
8. Engelman, A.; Englund, G.; Orenstein, J. M.; Martin, M. A.; Craigie, R. Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J. Virol. 1995, 69, 2729-2736.
9. Katz, R. A.; Merkel, G.; Kulkosky, J.; Leis, J.; Skalka, A. M. The avian retroviral IN protein is both necessary and sufficient for integrative recombination in vitro. Cell 1990, 63, 87-95.
10. Craigie, R.; Fujiwara, T.; Bushman, F. The IN protein of Moloney murine leukemia virus processes the viral DNA ends and accomplishes their integration in vitro. Cell 1990, 62, 829-837.
11. Katz, R. A.; Skalka, A. M. The retroviral enzymes. Annu. Rev. Biochem. 1994, 63, 133-173.
12. Vink, C.; Plasterk, R. H. A. The human immunodeficiency virus integrase protein. Trends Genet. 1993, 9, 433-437.
13. Engelman, A.; Mizuuchi, K.; Craigie, R. HIV-1 DNA integration: mechanism of viral DNA cleavage and DNA strand transfer. Cell 1991, 67, 1211-21.
14. Bushman, F. D.; Engelman, A.; Palmer, I.; Wingfield, P.; Craigie, R. Domains of the integrase protein of human immunodeficiency virus type 1 responsible for polynucleotidyl transfer and zinc binding. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 3428-3432.
15. Chow, S. A.; Vincent, K. A.; Ellison, V.; Brown, P. O. Reversal of integration and DNA splicing mediated by integrase of human immunodeficiency virus. Science 1992, 255, 723-726.
16. Pommier, Y.; Kohlhagen, G.; Kohn, K. W.; Leteurtre, F.; Wani, M. C.; Wall, M. E. Interaction of an alkylating camptothecin derivative with a DNA base at topoisomerase I-DNA cleavage sites. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 8861-8865.
17. Vink, C.; Yeheskiely, E.; van der Marel, G. A.; van Boom, J. H.; Plasterk, R. H. Site-specific hydrolysis and alcoholysis of human immunodeficiency virus DNA termini mediated by the viral integrase protein. Nucl. Acids Res. 1991, 19, 6691-8.
18. Kulkosky, J.; Jones, K. S.; Katz, R. A.; Mack, J. P.; Skalka, A. M. Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases. Mol. Cell Biol. 1992, 12, 2331-2338.
19. Engelman, A.; Hickman, A. B.; Craigie, R. The core and carboxyl-terminal domains of the integrase protein of human immunodeficiency virus type 1 each contribute to nonspecific DNA binding. J. Virol. 1994, 68, 5911-5917.
20. (20l Gupta, M.; Fujimori, A.; Pommier, Y. Eukaryotic DNA topoisomerases I. Biochim. Biophys. Acta 1995, 1262, 1-14.
21. Mazumder, A.; Neamati, N.; Sommadossi, J.-P.; Gosselin, G.; Schinazi, R. F.; Imbach, J.-L.; Pommier, Y. Effects of nucleotide analogues on human immunodeficiency virus integrase. Mol. Pharmacol. 1996, 49, 621-628.
22. Engelman, A.; Craigie, R. Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro. J. Virol. 1992, 66, 6361-6369.
23. Beese, L. S.; Steitz, T. A. Structural basis for the 3′-5′ exonuclease activity of Escherichia coli DNA polymerase I: a two metal ion mechanism. EMBO J. 1991, 10, 25-33.
24. Fesen, M.; Pommier, Y.; Leteurtre, F.; Hiroguchi, S.; Yung, J.; Kohn, K. W. Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds. Biochem. Pharmacol. 1994, 48, 595-608.
25. Brinkworth, R. I.; Stoermer, M. J.; Fairlie, D. P. Flavones are inhibitors of HIV-1 proteinase. Biochem. Biophys. Res. Commun. 1992, 188, 631-637.
26. Mazumder, A.; Gupta, M.; Perrin, D. M.; Sigman, D. S.; Rabinovitz, M.; Pommier, Y. Inhibition of human immunodeficiency virus type 1 integrase by a hydrophobic cation: the phenanthroline-cuprous complex. AIDS Res. Hum. Retroviruses 1995, 11, 115-125.
27. +1. Arch. Biochem. Biophys. 1995, 322, 127-134.
28. Perno, C. F.; Bergamini, A.; Pesce, C. D.; Milanese, G.; Capozzi, M.; Aquaro, S.; Thaisrivangs, S.; et al. Inhibition of the protease of human immunodeficiency virus blocks replication and infectivity of the virus in chronically infected macrophages. J. Infect. Dis. 1993, 168, 1148-1156.
29. Weislow, O. S.; Kiser, R.; Fine, D. L.; Bader, J.; Shoemaker, R. H.; Boyd, M. R. New soluble-formazan assay for HIV-1 cytopathic effects: Application to high-flux screening of synthetic and natural products for AIDS-antiviral activity. J. Natl. Cancer Inst. 1989, 81, 577-586.